Details werden geladen...
Moderna Shares Slide Despite Cancer Vaccine Cutting Melanoma Risk by 42%
Moderna shares continued to slide on Friday (October 23, 2026), after dropping nearly 18% in the previous session, despite positive late-stage results for its p
Ähnliche Seiten
mRNA cancer vaccine slashes melanoma death or recurrence risk by 42% | The Independent
https://www.independent.co.uk/news/world/americas/mrna-cancer-vaccine-moderna-merck-b3071828.html
Moderna Stock Selloff: Why positive cancer vaccine results failed to lift shares - Moderna Shares Crash After Cancer Vaccine Data | The Economic Times
https://economictimes.indiatimes.com/markets/us-stocks/news/moderna-stock-selloff-why-positive-cancer-vaccine-results-failed-to-lift-shares/slideshow/135137094.cms
Moderna Stock Plunges 18% As Leaked Melanoma Vaccine Data Underperforms | 22.10.26 | finanzen.ch
https://www.finanzen.ch/nachrichten/aktien/moderna-stock-plunges-18percent-as-leaked-melanoma-vaccine-data-underperforms-1036656953Moderna stock crashes 25%, loses about $24 billion after cancer vaccine data leak - The Economic Times
https://economictimes.indiatimes.com/markets/us-stocks/news/moderna-shares-plummet-25-loses-about-24-billion-after-cancer-vaccine-data-leak/articleshow/135127206.cms
Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42% - Ars Technica
https://arstechnica.com/health/2026/10/personalized-mrna-cancer-vaccine-cut-melanoma-death-recurrence-by-42/